GlassScriptPhysician profile
Randolph Y Chang
NPI 1497781488
$10,715.67
in general payments reported to CMS, 2019-2025
39 companies · $138 in 2025
The $138 reported for 2025 was less than what a typical Pain Medicine (Anesthesiology) provider received nationally (typical 2025 total: $458).
See the full distribution for Pain Medicine (Anesthesiology)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,515 · 2020: $4,060 · 2021: $1,333 · 2022: $1,755 · 2023: $1,915 · 2025: $138.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,323 · Travel and Lodging: $730.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,323.46 |
| Travel and Lodging | $729.59 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $2,701.41 | 2019-2023 | Proclaim |
| Aesculap, INC. | $1,637.66 | 2020 | |
| Medtronic, INC. | $1,211.86 | 2022-2023 | Intellis Adaptivestim |
| Medtronic Vascular, INC. | $984.14 | 2020 | |
| Si-Bone, INC. | $561.15 | 2019-2023 | |
| Stimwave Technologies Incorporated | $460.18 | 2019-2022 | |
| Zyla Life Sciences, INC. | $304.13 | 2019-2020 | |
| Spr Therapeutics, INC | $292.13 | 2022 | |
| Stryker Corporation | $277.97 | 2020 | |
| Vertos Medical, INC. | $219.78 | 2020-2023 | Mild Device Kit |
| Collegium Pharmaceutical, INC. | $217.19 | 2019-2021 | |
| Boston Scientific Corporation | $202.18 | 2019-2022 | |
| Electronic Waveform Lab, INC. | $182.69 | 2019 | |
| Abbvie INC. | $140.54 | 2021-2022 | |
| Nevro Corp. | $129.06 | 2019-2023 | Senza |
Show all 39 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Scilex Pharmaceuticals INC. | $120.79 | 2019-2021 | |
| Pfizer INC. | $104.72 | 2019-2021 | |
| Foundation Fusion Solutions, LLC | $97.11 | 2025 | |
| Arbor Pharmaceuticals, INC. | $81.22 | 2019-2021 | |
| Medtronic USA, INC. | $74.69 | 2019 | |
| Biodelivery Sciences International, INC. | $68.20 | 2019-2021 | |
| Novartis Pharmaceuticals Corporation | $61.44 | 2019-2021 | |
| Almatica Pharma LLC | $60.43 | 2021 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $58.63 | 2019-2022 | |
| Horizon Therapeutics Plc | $55.66 | 2019-2022 | |
| Supernus Pharmaceuticals, INC. | $55.00 | 2019-2022 | |
| Lilly USA, LLC | $51.34 | 2019-2020 | |
| Assertio Therapeutics, INC. | $42.42 | 2019-2020 | |
| Mindray Ds USA, INC. | $41.08 | 2025 | A7 Anesthesia System |
| Hikma Pharmaceuticals USA | $39.72 | 2022 | |
| Fidia Pharma USA INC. | $24.42 | 2019-2020 | |
| Relievant Medsystems, INC. | $23.05 | 2020 | |
| Avanos Medical | $22.32 | 2022 | |
| Uswm, LLC | $20.93 | 2022 | |
| Redhill Biopharma INC. | $20.53 | 2020 | |
| Ibsa Pharma INC. | $18.21 | 2021 | |
| Grt US Holding, INC. | $17.91 | 2022 | |
| Painteq LLC | $17.57 | 2023 | Painteq |
| Bioventus LLC | $16.21 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Randolph Chang listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.